Point source concentration of GDNF may explain failure of phase II clinical trial

Michael F. Salvatore, Yi Ai, Brent Fischer, Amanda M. Zhang, Richard C. Grondin, Zhiming Zhang, Greg A. Gerhardt, Don M. Gash

Research output: Contribution to journalArticle

180 Scopus citations

Fingerprint Dive into the research topics of 'Point source concentration of GDNF may explain failure of phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences